-
effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
January 01, 2012 - limitations within the patient population, including low adherence to treatment
recommendations and medication … approved therapies, especially because the
newer intervention requires a shift from at-home oral medication … are
associated with limitations including low patient adherence to treatment recommendations and
medication … approved therapies, especially because the newer intervention
requires a shift from at-home oral medication … s potential to improve health outcomes in terms
of opioid and methadone addiction, adherence, and medication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - medical stable (COWS score ≤5, no acute opioid withdrawal); resident of one of two counties; presence of medication … prisoners); co-occurring psychiatric disorder; cardiac or pulmonary issues; homeless or on parole; current medication … functioning, depression, or drug use Harms not reported by treatment group
Suspected abuse of study medication … enhanced Charlson comorbidity score; diagnoses for chronic non-cancer pain and mental health conditions; medication
-
effectivehealthcare.ahrq.gov/products/abnormal-uterine-bleeding/research-protocol
November 21, 2011 - excluding irregular and unpredictable patterns of bleeding, fibroids, polyps, adenomyosis, cancers, medication … /menstrual patterns of bleeding and bleeding associated with fibroids, polyps, adenomyosis, cancer, medication … unpredictable patterns of bleeding and bleeding associated with fibroids, polyps, adenomyosis, cancer, medication … thyroid disease, coagulopathy), structural abnormalities (e.g., fibroids, adenomyosis), cancer, or medication … excluding irregular and unpredictable patterns of bleeding, fibroids, polyps, adenomyosis, cancers, medication
-
effectivehealthcare.ahrq.gov/products/weight-gain-prevention/research-protocol
October 25, 2011 - at high risk of gaining weight because of a family history of obesity or diabetes mellitus or use of medication … Interventions:
For KQ1-6: Self-management, dietary, physical activity, medication or a combination … Orlistat, the Food and Drug Administration (FDA)-approved medication for long-term (>1 year) weight control … Orlistat is the only medication that will be included.Lifestyle interventions will be included under … Trends in and patterns of obesity reduction medication use in an insured cohort.
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
January 01, 2012 - approved therapies, especially because the
newer interventions require a shift from at-home oral medication … approved therapies, especially because the newer interventions require a shift from
at-home oral medication … intervention’s potential to improve health
outcomes, in terms of opioid and methadone addiction, medication … available therapies, but some experts stated that if adherence is improved and the need for daily
medication … intervention if it is proven to be more convenient for patients and reduces the need for daily
medication
-
effectivehealthcare.ahrq.gov/products/crohns-disease/research
February 25, 2014 - For children, the strength of evidence was low or insufficient to support the efficacy of any medication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0367_11-08-2010.pdf
January 01, 2010 - access points (e.g., ob/gyn, pediatrician, community based, primary care),
various screening tools, medication
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-235-pharma-nonpharma-ptsd-update-summary.pdf
November 01, 2020 - The updated report
now includes 115 pharmacologic studies (trials with at least one medication arm) … and 274
nonpharmacologic studies (trials with no medication arms – all other types of studies
including
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/use-telehealth-during-COVID-19-executive-summary.pdf
January 01, 2023 - There was a mostly lower rate of missed visits, lower rate of change
in therapy/medication, higher rate … of therapy/medication adherence, but lower rate of up-
to-date labs and paraclinical assessment among
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharma-ptsd-update-summary.pdf
November 01, 2020 - The updated report
now includes 115 pharmacologic studies (trials with at least one medication arm) … and 274
nonpharmacologic studies (trials with no medication arms – all other types of studies
including
-
effectivehealthcare.ahrq.gov/products/antipsychotics-adults/research-protocol
December 01, 2010 - Medication adherence and persistent use (and associated dosing, time to discontinuation of treatment) … We will compare medication-associated adverse events in FGAs and SGAs (KQ3). … Medication adherence and persistent use (associated dosing, time to discontinuation of treatment). … to have experienced the event and the total number of patients in the medication groups in relevant … The dose of each medication that is associated with an adverse event will be recorded to facilitate a
-
effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
March 29, 2012 - attempt to compare the safety
or effectiveness between CCBs and other classes
of antihypertensive medication … Patients who start a preventive
medication may have a disposition that makes
them more likely to seek … the time of registry enrollment rather
than at the time of treatment initiation in an
established medication … comparing adverse
effects of medications that are thought to occur
only in proximity to using the medication … Associations of kidney function with
cardiovascular medication use after
myocardial infarction.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
June 01, 2012 - BP mmHg:
Time 0
SBP: 142 ± 21 vs. 162 ± 17; p:NR
DBP: 73 ± 13 vs. 75 ± 13; p:NR
Medication … (n): 4 vs. 3.5; p:NR
Month 3:
SBP: 152 ± 12 vs. 148 ± 21; p:NR
DBP: 73 ± 8 vs. 80 ± 15; p:NR
Medication … (n): 4 vs. 3; p<0.05
Month 48
SBP: 137 ± 37 vs. 166 ± 30; p:NR
DBP: 78 ± 28 vs. 80 ± 20; p:NR
Medication … Minor side effects of medication
were reported in 15 patients in the
medication group and 4 in the … (n): 4 vs. 3.5; p:NR
Month 3:
SBP: 152 ± 12 vs. 148 ± 21; p:NR
DBP: 73 ± 8 vs. 80 ± 15; p:NR
Medication
-
effectivehealthcare.ahrq.gov/products/aggression/research-protocol
October 06, 2015 - A case in point might be increasing the dose or adding an as-needed dose of an antipsychotic medication … When successful, such medication-based steps can help prevent aggression. 42
Furthermore, recognizing … The latter include, for example, the medication protocols described in the emergency department-focused … aggression for those who are actively aggressive, such as:
Psychiatric Emergency Response Teams
Medication … aggression for those who are actively aggressive, such as:
Psychiatric Emergency Response Teams
Medication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ocd-draft-report-kq2-appendix.xlsx
January 01, 2023 - ERP/Exposure CBT Yes No 6 18 Inadequate OCD symptom severity CY-BOCS (continuous) postreatment score Medication … Exposure CBT Yes Yes 4 25 Adequate OCD symptom severity CY-BOCS (continuous) postreatment score SSRI medication … Exposure CBT Yes Yes 4 15 Adequate OCD symptom severity CY-BOCS (continuous) postreatment score SSRI medication … ERP/Exposure CBT Yes No 6 18 Inadequate OCD symptom severity CY-BOCS (continuous) postreatment score medication … ERP/Exposure inpatient ERP Yes Yes 15 12 Adequate OCD symptom severity CY-BOCS (continuous) reduction Medication
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
December 29, 2020 - Pain
management patients are not abusers of
the medication. … The only medication
that works for us is Opioids for pain. … Once we found the correct amount of
Oxycontin Extended Release, I was stable
on that medication for … I did not
have to up the dose, I did have from the
doctor a "As needed opioid medication for
times … More research needs to be done
because opiates are very Effective pain
medication.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0108_05-24-2009.pdf
January 01, 2009 - of efficacy, adverse effects, potential
for addiction or recidivism, and the risk of development of medication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0576-150420.pdf
December 10, 2014 - in mental health settings,
including increased staffing levels, staff training, increased patient medication
-
effectivehealthcare.ahrq.gov/products/antipsychotics-children-update/research-protocol
December 07, 2015 - The category includes schizophrenia, schizoaffective disorder, substance/medication-induced psychotic … , nonpharmacological therapy, as reported); medication dose. … A three-country comparison of psychotropic medication prevalence in youth. … Antipsychotic medication prescribing in children enrolled in Medicaid. … Use of psychotropic medication in children and adolescents with autism spectrum disorders.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
May 01, 2012 - No clear relationship was identified between duration of medication use
and outcomes. … Other cohort studies suggest that long-term use of medication improves grade
retention and academic … They also ranked highly the need for efficacy and effectiveness
studies of medication and psychosocial … Psychotherapeutic medication prevalence in
Medicaid-insured preschoolers. … Prevalence of diagnosis and medication
treatment for attention-deficit/hyperactivity
disorder--United